Waters, Labcorp To Expand Access To Cervical Cancer Screening With BD Onclarity HPV Assay
Oct 23 (Reuters) -
WATERS AND LABCORP TO EXPAND ACCESS TO CERVICAL CANCER SCREENING WITH THE MOST COMPREHENSIVE FDA-APPROVED HPV TESTING OPTION BEGINNING IN LATE 2026
WATERS CORP - CO AND LABCORP TO OFFER BD ONCLARITY HPV ASSAY BY END OF 2026
Further company coverage: LH.NWAT.N